Fig. 7From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinomaHistological studies of the liver tissues obtained from the control, carcinogen, and harmalol pre- and post-treated groups. a After the 1st week, b after the 7th week, c after the 14th week and d after the 21st weekBack to article page